Related Experiment Video
Updated: Aug 18, 2025
08:52
Chemical Dimerization-Induced Protein Condensates on Telomeres
Published on: April 12, 2021
3.2K
Principles and functions of condensate modifying drugs
Avinash Patel1, Diana Mitrea2, Vigneshwaran Namasivayam3
1Dewpoint Therapeutics GmbH, Dresden, Germany.
Frontiers in Molecular Biosciences
|December 9, 2022
Summary
Biomolecular condensates, lacking membranes, are crucial cellular components often linked to diseases and "undruggable" targets. This review classifies drugs modulating these condensates as dissolvers, inducers, localizers, or morphers, aiding new therapy discovery.
Area of Science:
- Cell Biology
- Biochemistry
- Drug Discovery
Background:
- Biomolecular condensates are membrane-less cellular compartments.
- They are vital for cellular processes but implicated in diseases.
- Many condensate targets are considered
Purpose of the Study:
- To review how drugs modulate biomolecular condensate structure and function.
- To classify these drug effects into distinct phenotypic categories.
- To highlight the therapeutic potential of condensate modifiers (c-mods).
Main Methods:
- Phenotypic classification of drugs based on condensate modulation: dissolvers, inducers, localizers, and morphers.
- Discussion of various bioactive molecules acting as c-mods (small molecules, oligonucleotides, peptides).
- Review of current understanding of c-mod mechanisms.
Main Results:
- Drugs can be categorized by their impact on condensate properties.
- A diverse range of molecules, termed c-mods, are identified.
- Understanding c-mod mechanisms is key to therapeutic development.
Conclusions:
- Modulating biomolecular condensates offers a novel therapeutic strategy.
- Classifying c-mods provides a framework for drug development.
- Targeting condensates may unlock treatments for challenging diseases.
Related Concept Videos
01:24Principles of Drug Action
6.3K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.3K
01:30Prodrugs
2.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.7K
01:26Enhanced Elimination of Poison
563
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
563
01:14Phase II Conjugation Reactions: Overview
273
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
273
01:26Targets for Drug Action: Overview
7.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.0K
01:27Phase I Reactions: Reductive Reactions
248
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
248